A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)
University Hospital, Grenoble
694 participants
Jan 24, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate peri and post-operative outcomes as well as long-term survival of 3D IGRAPN compared to conventional Robot-Assisted Partial Nephrectomy (RAPN) for moderate and highly complex renal tumors. The main questions aim to answer: * peri-operative complications * oncological safety * long term renal function Participants will be asked to do undergo 3D-IGRAPN. Researchers will compare 3D-IGRAPN to RAPN to see if peri-operative outcomes are better in the experimental group.
Eligibility
Inclusion Criteria6
- Patients over 18 years
- Indication of RAPN for suspicious renal tumor
- Moderate or high complexity renal tumor (RENAL Nephrometry Score (NS) \>7)
- Da Vinci® surgical system available for the surgery
- Patient affiliated to the French social security system or an equivalent system
- Signed informed consent form UroCCR and ACCURATE
Exclusion Criteria4
- Medical contraindication to RAPN
- Renal insufficiency forbidding iodine injection
- Patient with allergy to iodinated contrast products
- Patient concerned by articles L1121-5 to 8 of the French public health code (protected persons)
Interventions
patient have a partial nephrectomy for renal complex tumor
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05572216